Latest news
Hopstem’s iPSC-Derived hNPC01 Cell Therapy Gains FDA Clearance to Target Three Major Brain Injury Indications - BioInformantBioInformant · Wed, 05 Aug 2026 21:57:41 GMTCoast Guard Vows to Protect Crews From Brain Injuries Caused by Rough Seas - The New York TimesThe New York Times · Fri, 31 Jul 2026 07:00:00 GMTHopstem Receives U.S. FDA IND Clearance and Fast Track - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 06:54:24 GMT